Literature DB >> 2457865

Specificity of monoclonal antibodies against group B streptococcus type II and inhibition of their binding by human secretions.

B M Gray1, M L Egan, D G Pritchard.   

Abstract

Mouse monoclonal antibodies against the type-specific polysaccharide antigen of type II group B Streptococcus may be divided into two general groups based on their antigen-binding properties. One group of antibodies binds to both intact and desialylated type II antigen and the binding can be inhibited by beta-galactopyranosides. The second group of antibodies react only with intact type II polysaccharide and are not inhibited by beta-galactopyranosides. The binding of antibodies of the first group can also be inhibited by carbohydrate components of normal human secretions that share structural similarities with the type II polysaccharide. The binding of antibodies of one specificity precluded the binding of antibodies of the other specificity, apparently by competing for binding sites within a combining area that includes both determinants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457865     DOI: 10.1203/00006450-198807000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.

Authors:  Ross Perko; Guolian Kang; Anusha Sunkara; Wing Leung; Paul G Thomas; Mari H Dallas
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-16       Impact factor: 5.742

2.  Seroepidemiology of group B Streptococcus type II antibody specificity.

Authors:  B M Gray; D G Pritchard; J D Springfield; R J Benak; H C Dillon
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

3.  Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides.

Authors:  D G Pritchard; B M Gray; M L Egan
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women.

Authors:  Lindsey R Burcham; Brady L Spencer; Lauryn R Keeler; Donna L Runft; Kathryn A Patras; Melody N Neely; Kelly S Doran
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

Review 5.  Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?

Authors:  Kirsty Le Doare; Beate Kampmann
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

6.  SIgA, TGF-β1, IL-10, and TNFα in Colostrum Are Associated with Infant Group B Streptococcus Colonization.

Authors:  Kirsty Le Doare; Katie Bellis; Amadou Faal; Jessica Birt; Daniel Munblit; Holly Humphries; Stephen Taylor; Fiona Warburton; Paul T Heath; Beate Kampmann; Andrew Gorringe
Journal:  Front Immunol       Date:  2017-10-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.